IP Library › Granted Patent US 11,001,847
Granted Patent B2
US 11,001,847 · App. 16/893,935 · Granted May 11, 2021

Aptamers against

Inventors: Ronald J. Shannon (Malvern, PA); Michael McIntyre (Malvern, PA); David Bunka (York, GB); Edward Barnes (York, GB)
Assignee: Biovector, Inc.
C12N15/115C12Q1/689C12N2310/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,001,847
App. No.
16/893,935
Filed
Jun 5, 2020
Granted
May 11, 2021
Kind
B2
Examiner
SHIN, DANA H
Art Unit
1635
USPC
435/61
Abstract

Compositions comprising aptamers capable of specifically binding to a surface protein of Clostridium difficile spore are provided. A method for detecting, enriching, separating, and/or isolating Clostridium difficile spores is provided.

Claims (13)

1. A method of visualizing Clostridium difficile spores on a surface, comprising:

contacting a surface with an aptamer having a specific binding affinity for a surface protein of Clostridium difficile spore, wherein the aptamer comprises a nucleic acid sequence having at least 90% identity with the nucleic acid sequence as set forth in SEQ ID NO: 11, and wherein the surface protein is CotE; and

visualizing the presence or absence of C. difficile spores on the surface.

2. The method of claim 1 , further comprising washing of the surface after the contacting to remove unbound aptamer.

3. The method of claim 1 , wherein the aptamer is conjugated to a detectable moiety thereby forming an aptamer conjugate.

4. The method of claim 3 , wherein the detectable moiety is a fluorophore.

5. The method of claim 4 , wherein the fluorophore emits at a wavelength of between about 500 nm and 510 nm.

6. The method of claim 4 , further comprising illuminating the surface with a light source.

7. The method of claim 6 , wherein light from the light source has a predetermined wavelength, and the predetermined wavelength corresponds to a wavelength of light emitted by the detectable moiety of the aptamer conjugate.

8. The method of claim 6 , wherein the light source is configured to produce light at a wavelength of between about 485 nm and 515 nm.

9. The method of claim 6 , further comprising filtering the light produced by the light source.

10. The method of claim 6 , comprising passing the light produced from the light source through a bandpass filter.

11. The method of claim 10 , further comprising photographing a location on the surface, and detecting the presence or absence of the conjugated aptamer bound to Clostridium difficile spores.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2021
From: BIOVECTOR, INC.
To: LIV PROCESS, INC.
Reel/Frame 058796/0180 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2020
From: SHANNON, RONALD J.; MCINTYRE, MICHAEL; BUNKA, DAVID; BARNES, EDWARD
To: BIOVECTOR, INC.
Reel/Frame 053899/0372 →
Continuity (3)
Provisional Application 62857639 · Jun 5, 2019
Provisional Application 62983095 · Feb 28, 2020
Related Publication 20200385730A1 · Dec 10, 2020
Cited By (2)
US 12,338,442 US 12,708,119